IL150121A0 - Antipruritic agents for external use - Google Patents

Antipruritic agents for external use

Info

Publication number
IL150121A0
IL150121A0 IL15012100A IL15012100A IL150121A0 IL 150121 A0 IL150121 A0 IL 150121A0 IL 15012100 A IL15012100 A IL 15012100A IL 15012100 A IL15012100 A IL 15012100A IL 150121 A0 IL150121 A0 IL 150121A0
Authority
IL
Israel
Prior art keywords
external use
antipruritic agents
weight
antipruritic
aspirin
Prior art date
Application number
IL15012100A
Other languages
English (en)
Original Assignee
Teikoku Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Seiyaku Kk filed Critical Teikoku Seiyaku Kk
Publication of IL150121A0 publication Critical patent/IL150121A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Prostheses (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL15012100A 1999-12-28 2000-12-15 Antipruritic agents for external use IL150121A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP37354799 1999-12-28
PCT/JP2000/008888 WO2001047525A1 (fr) 1999-12-28 2000-12-15 Agent antipruritique a usage externe

Publications (1)

Publication Number Publication Date
IL150121A0 true IL150121A0 (en) 2002-12-01

Family

ID=18502352

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15012100A IL150121A0 (en) 1999-12-28 2000-12-15 Antipruritic agents for external use
IL150121A IL150121A (en) 1999-12-28 2002-06-09 Anti-itching agents for external use

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL150121A IL150121A (en) 1999-12-28 2002-06-09 Anti-itching agents for external use

Country Status (17)

Country Link
US (1) US20030125308A1 (ko)
EP (1) EP1249239B1 (ko)
JP (1) JP4813725B2 (ko)
KR (1) KR20020068385A (ko)
CN (1) CN1414856A (ko)
AT (1) ATE395920T1 (ko)
AU (1) AU779590B2 (ko)
CA (1) CA2394471C (ko)
DE (1) DE60038979D1 (ko)
ES (1) ES2304989T3 (ko)
HU (1) HU228233B1 (ko)
IL (2) IL150121A0 (ko)
MX (1) MXPA02006447A (ko)
NO (1) NO330872B1 (ko)
NZ (1) NZ519783A (ko)
WO (1) WO2001047525A1 (ko)
ZA (1) ZA200204624B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4868687B2 (ja) * 2002-09-30 2012-02-01 帝國製薬株式会社 ケロイド等の形成抑制外用剤
JP2004262776A (ja) * 2003-02-21 2004-09-24 Teikoku Seiyaku Co Ltd 血管新生促進剤
JP4791682B2 (ja) * 2003-02-21 2011-10-12 帝國製薬株式会社 痔疾患用治療剤
EP1716854A4 (en) * 2004-02-16 2010-01-20 Teikoku Seiyaku Kk EXTERNAL PREPARATION FOR TREATING PAINFUL SKIN WOUNDS
US20070196460A1 (en) * 2004-02-16 2007-08-23 Yukiko Inamoto External preparation for treating skin or mucosal injury caused by viral infection
EP1656935A1 (en) * 2004-11-12 2006-05-17 Cognis IP Management GmbH Use of physiologically active fatty acids for the treatment of pruritus
CN101380317B (zh) * 2007-09-07 2010-12-08 英属开曼群岛商安盛开发药物股份有限公司 减缓搔痒症的药学组合物
AU2008334222B2 (en) * 2007-12-11 2013-07-18 Medrx Co., Ltd. Tape preparation comprising etodolac in ionic liquid form
JP2010120912A (ja) * 2008-11-21 2010-06-03 Lead Chemical Co Ltd ５−メチル−１−フェニル−２−（１ｈ）−ピリドン含有貼付剤

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126681A (en) * 1975-12-08 1978-11-21 The Procter & Gamble Company Topical composition containing acetyl salicylic acid
US4032662A (en) * 1976-01-05 1977-06-28 Idabelle K. Mannear Method for the treatment of contact allergic dermatitis
US4219548A (en) * 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
US4395420A (en) * 1981-12-09 1983-07-26 Bernstein Joel E Method and composition for treating pruritis
US4822604A (en) * 1985-05-20 1989-04-18 S. C. Johnson & Son, Inc. Local treatment of dandruff, seborrheic dermatitis, and psoriasis
US4797402A (en) * 1987-06-02 1989-01-10 Dorsey Kenneth E Cooling anti-itch skin preparations
JPS6429315A (en) * 1987-07-23 1989-01-31 Tokyo Medeitsuku Kk Drug for athlete's foot
US4975269A (en) * 1989-07-31 1990-12-04 Leonard Chavkin Shelf stable aspirin solutions
JP2501671B2 (ja) * 1991-02-04 1996-05-29 救急薬品工業株式会社 高放出性鎮痒貼付剤
GB9104286D0 (en) * 1991-02-28 1991-04-17 Phytopharm Ltd Pharmaceutical compositions for the treatment of skin disorders
US5240917A (en) * 1991-04-03 1993-08-31 Keimowitz Rudolph M Suppression of thromboxane levels by percutaneous administration of aspirin
JPH05286860A (ja) * 1992-04-03 1993-11-02 Kowa Co ゲル軟膏剤
EP0885611A3 (en) * 1992-09-24 1999-01-07 Sepracor, Inc. Methods and compositions for treating allergic disorders using optically pure (+) cetirizine
US6300326B1 (en) * 1994-11-02 2001-10-09 Michael R. Dobbs Composition and method for control and treatment of cutaneous inflammation
KR100387156B1 (ko) * 1995-04-21 2003-10-11 세키스이가가쿠 고교가부시키가이샤 피부질환치료용외용제
US5776920A (en) * 1995-08-02 1998-07-07 Quarles; Ruth Method for treatment of psoriasis
US5932230A (en) * 1997-05-20 1999-08-03 Degrate; Frenchell Topical analgesic formulation containing fruits, oils and aspirin
US6372234B1 (en) * 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
JPH1112177A (ja) * 1997-06-25 1999-01-19 Teikoku Seiyaku Co Ltd 安定なアスピリン含有外用製剤
ATE283707T1 (de) * 1998-01-13 2004-12-15 Daiichi Suntory Pharma Co Ltd Antibakterille zusammensetzung zur topischen anwendung, enthaltend faropenem
US6423343B1 (en) * 1998-01-23 2002-07-23 Usbiomaterials Corporation Bioactive glass treatment of inflammation in skin conditions
US6960579B1 (en) * 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6177413B1 (en) * 2000-03-03 2001-01-23 Natalie Blahut Stabilized aspirin compositions and method of preparation for oral and topical use
IL151125A0 (en) * 2000-03-21 2003-04-10 Procter & Gamble Heterocyclic side chain containing, n-substituted metalloprotease inhibitors
US7087556B2 (en) * 2001-04-16 2006-08-08 Wsp Chemicals & Technology, L.L.C. Compositions for treating subterranean zones penetrated by well bores
ATE406867T1 (de) * 2001-07-18 2008-09-15 Unilever Nv Zusammensetzungen für die behandlung von haaren und/oder kopfhaut
WO2003086449A1 (en) * 2002-04-12 2003-10-23 Yale University ANTI-INFLAMMATORY AND WOUND HEALING EFFECTS OF LYMPHOID THYMOSIN β 4
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
DE10256629B3 (de) * 2002-12-03 2004-02-19 Schott Glas Vorzugsweise Pb- und As-freie optische Gläser mit Tg ≦ 500°C und deren Verwendung
US20060275230A1 (en) * 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
US8003127B2 (en) * 2005-03-23 2011-08-23 Elan Pharma International Limited Nanoparticulate corticosteroid and antihistamine formulations methods of making, and methods of administering thereof
US20070110739A1 (en) * 2005-11-11 2007-05-17 Logsdon Lawrence M Wipe away pain

Also Published As

Publication number Publication date
CA2394471C (en) 2010-05-25
ES2304989T3 (es) 2008-11-01
NZ519783A (en) 2005-05-27
KR20020068385A (ko) 2002-08-27
AU1890701A (en) 2001-07-09
CN1414856A (zh) 2003-04-30
IL150121A (en) 2009-07-20
HUP0204208A2 (hu) 2003-03-28
ATE395920T1 (de) 2008-06-15
EP1249239B1 (en) 2008-05-21
CA2394471A1 (en) 2001-07-05
HU228233B1 (en) 2013-02-28
NO20023111D0 (no) 2002-06-27
HUP0204208A3 (en) 2003-04-28
DE60038979D1 (de) 2008-07-03
AU779590B2 (en) 2005-02-03
EP1249239A4 (en) 2006-04-05
NO20023111L (no) 2002-06-27
NO330872B1 (no) 2011-08-01
WO2001047525A1 (fr) 2001-07-05
US20030125308A1 (en) 2003-07-03
EP1249239A1 (en) 2002-10-16
MXPA02006447A (es) 2003-09-22
JP4813725B2 (ja) 2011-11-09
ZA200204624B (en) 2003-01-22

Similar Documents

Publication Publication Date Title
DE59504653D1 (de) Reinigungsmittelstück für spültoiletten
PL318557A1 (en) Ligands of retinic acid x-receptors
CA2229077A1 (en) Lipid metabolism improving agent
AU4950993A (en) Combination of germicidal agents
IL150121A0 (en) Antipruritic agents for external use
CO5011115A1 (es) Compuestos y metodos quimioquina
ES2124424T3 (es) Azadioxacicloalquenos substituidos y su empleo como fungicidas.
EP0738142A4 (en) Perfluorocarbons as an anti-inflammatory agent
DK0789742T3 (da) Efterbehandlingsmiddel til vasketøj
PT666731E (pt) Elixir dentifrico antibacteriano
DE60040753D1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
DK0799239T3 (da) Diastereomert rene 3-oxo- og 3-thioxo-4-aza-androstan-derivater og anvendelse deraf som antiandrogener
DE60014369D1 (de) Propansäurederivate, die die bindung von integrinen an ihre rezeptoren behindern
CA2286919A1 (en) Spreading layers, wetting agents for their production and their use in test strips
IT1247945B (it) Agente avente attivita' batteriostatica e battericida
PL314131A1 (en) Bar soap
GR3026193T3 (en) Compositions for deodorising animal excreta, and deodorising method therefor
BG105533A (en) Aqueous based cleaning agent preparations forming vesicules, containing surfactants, method for their production and their utilization
MX9303557A (es) Metodo para la administracion de un antiandrogeno, en particular, espironolactona, a traves de la piel.
NZ187146A (en) Aqueous liquid detergent composition based on sodium soap
EP0712838A4 (en) ACYLPHENYLGLYCIN DERIVATIVE AND THIS PREVENTIVE AND HEALING AGENT CONTAINING ACTIVE SUBSTANCES AGAINST DISEASES CAUSED BY INCREASED COLLAGENASE ACTIVITY
FR2757399B1 (fr) Application de composes steroides substitues en 11 pour la fabrication de medicaments ayant une activite estrogene dissociee
NO983217L (no) Terapeutiske anti-astmamidler som inneholder selenforbindeler
TW325469B (en) 5,6-Dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes
CO4230267A1 (es) Metodo para la limpieza de tapetes